| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Louise Witten, Jesper Frank Bastlund, Birte Y Glenthøj, Christoffer Bundgaard, Björn Steiniger-Brach, Arne Mørk, Bob Oranj. Comparing Pharmacological Modulation of Sensory Gating in Healthy Humans and Rats: The Effects of Reboxetine and Haloperidol. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 41. issue 2. 2016-09-20. PMID:26129678. |
in the current study we aimed to investigate the involvement of the noradrenergic and dopaminergic neurotransmitter systems in sensory gating. |
2016-09-20 |
2023-08-13 |
human |
| Hugo González, Francisco Contreras, Rodrigo Pachec. Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 4. 2016-09-15. PMID:26018603. |
next, we discussed how alterations of neurotransmitter levels observed in the basal ganglia throughout the time course of pd progression could be strongly affecting the behaviour of encephalitogenic cd4+ t-cells and thereby the outcome of the neuroinflammatory process and the consequent neurodegeneration of dopaminergic neurons. |
2016-09-15 |
2023-08-13 |
Not clear |
| Magdalena Zaniewska, Małgorzata Filip, Edmund Przegalinsk. The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction. Current neuropharmacology. vol 13. issue 3. 2016-08-09. PMID:26411968. |
although it is generally accepted that the abuse-related effects of amphetamines and cocaine result from the activation of the brain dopaminergic (da) system, the psychostimulants also alter other neurotransmitter systems. |
2016-08-09 |
2023-08-13 |
Not clear |
| Noble George, Emily G Gean, Ayon Nandi, Boris Frolov, Eram Zaidi, Ho Lee, James R Brašić, Dean F Won. Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use. CNS drugs. vol 29. issue 4. 2016-06-13. PMID:25948171. |
other prevalent pet and spect neurotransmitter system agents, including those newly us fda-approved imaging agents related to the dopaminergic system, are included. |
2016-06-13 |
2023-08-13 |
Not clear |
| Anshuman Singh, Anubha Mudawal, Rajendra K Shukla, Sanjay Yadav, Vinay K Khanna, Rao Sethumadhavan, Devendra Parma. Effect of Gestational Exposure of Cypermethrin on Postnatal Development of Brain Cytochrome P450 2D1 and 3A1 and Neurotransmitter Receptors. Molecular neurobiology. vol 52. issue 1. 2016-05-17. PMID:25288152. |
similar alterations were observed in the expression of gabaergic, muscarinic, dopaminergic, and serotonergic neurotransmitter receptors in brain regions of rat offsprings. |
2016-05-17 |
2023-08-13 |
rat |
| Manale Bensaid, Patrick P Michel, Stewart D Clark, Etienne C Hirsch, Chantal Françoi. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease. Experimental neurology. vol 275 Pt 1. 2016-04-29. PMID:26571193. |
lastly, when the ppn cholinergic lesion was performed in rats in which the dopaminergic lesion induced by 6-ohda was in progress, loss of cholinergic neurons was more drastic than when each neurotransmitter system was lesioned separately. |
2016-04-29 |
2023-08-13 |
rat |
| Thomas P K Breckel, Carsten Giessing, Anja Gieseler, Sarah Querbach, Martin Reuter, Christiane M Thie. Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes. PloS one. vol 10. issue 6. 2016-04-21. PMID:26079805. |
recent findings indicate that genetic variations that affect the cholinergic and dopaminergic neurotransmitter system impact performance in cognitive tasks and effects of nicotine. |
2016-04-21 |
2023-08-13 |
human |
| A Rieckmann, S N Gomperts, K A Johnson, J H Growdon, K R A Van Dij. Putamen-midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases. NeuroImage. Clinical. vol 8. 2016-04-04. PMID:26137443. |
in line with the hypothesis that functional connectivity between the midbrain and the putamen reflects the integrity of the dopaminergic neurotransmitter system, putamen-midbrain functional connectivity was significantly correlated with striatal dat availability even after stringent control for effects of head motion. |
2016-04-04 |
2023-08-13 |
Not clear |
| Walter J Schulz-Schaeffe. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease? Biomolecules. vol 5. issue 3. 2016-03-25. PMID:26193328. |
currently, the pathophysiology of idiopathic parkinson's disease is explained by a loss of mainly dopaminergic nerve cells that causes a neurotransmitter deficiency. |
2016-03-25 |
2023-08-13 |
mouse |
| Maell Cullen, KongFatt Wong-Li. Integrated dopaminergic neuronal model with reduced intracellular processes and inhibitory autoreceptors. IET systems biology. vol 9. issue 6. 2016-03-25. PMID:26577159. |
dopamine (da) is an important neurotransmitter for multiple brain functions, and dysfunctions of the dopaminergic system are implicated in neurological and neuropsychiatric disorders. |
2016-03-25 |
2023-08-13 |
Not clear |
| Annabel Vreeker, Annet H van Bergen, René S Kah. Cognitive enhancing agents in schizophrenia and bipolar disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 25. issue 7. 2016-03-14. PMID:25957798. |
this review focuses on the pharmacological agents with putative effects on cognition in both schizophrenia and bipolar illness; specifically agents targeting the dopaminergic, cholinergic and glutamatergic neurotransmitter pathways in schizophrenia and the cognitive effects of lithium, anticonvulsants and antipsychotics in bd. |
2016-03-14 |
2023-08-13 |
Not clear |
| A F Leentjens, F R Verhey, F W Vreeling, H M van Praa. The role of serotonin in Parkinsons' Disease: An integrated approach for research of motor, cognitive and affective symptoms with functional intervention studies. Acta neuropsychiatrica. vol 10. issue 4. 2016-03-14. PMID:26971892. |
serotonin seems to play an important role in the regulation of dopaminergic and cholinergic neurotransmitter activities. |
2016-03-14 |
2023-08-13 |
Not clear |
| Rhona Clarke, Louise Adermar. Dopaminergic Regulation of Striatal Interneurons in Reward and Addiction: Focus on Alcohol. Neural plasticity. vol 2015. 2016-03-08. PMID:26246915. |
dopamine is a key neurotransmitter in reward and reward-guided learning, and the physiological activity of gabaergic and cholinergic interneurons is regulated by dopaminergic transmission in a complex manner. |
2016-03-08 |
2023-08-13 |
Not clear |
| Gyuri Kim, Ho-Sun Lee, Joon Seok Bang, Boram Kim, Dahae Ko, Mihi Yan. A current review for biological monitoring of manganese with exposure, susceptibility, and response biomarkers. Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews. vol 33. issue 2. 2016-02-19. PMID:26023759. |
however, overexposure to mn causes manganism, a motor syndrome similar to parkinson disease, via interference of the several neurotransmitter systems, particularly the dopaminergic system in areas. |
2016-02-19 |
2023-08-13 |
Not clear |
| Hyung Eun Lee, Young Woo Lee, Se Jin Park, Se Jin Jeon, Eunji Kim, Sunhee Lee, Ah-Reum Han, Eun-Kyoung Seo, Jong Hoon Ry. 4-Hydroxybenzyl methyl ether improves learning and memory in mice via the activation of dopamine D1 receptor signaling. Neurobiology of learning and memory. vol 121. 2016-01-22. PMID:25843525. |
taken together, these results suggest that the effect of hbme on cognitive functions may be partly involved in dopaminergic neurotransmitter signaling and that hbme could be a potential therapeutic agent for treating the cognitive dysfunction induced by dopaminergic or cholinergic neurotransmitter system deficits. |
2016-01-22 |
2023-08-13 |
mouse |
| L Scoriels, R M Salek, E Goodby, D Grainger, A M Dean, J A West, J L Griffin, J Suckling, P J Nathan, B R Lennox, G K Murray, E T Bullmore, P B Jone. Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission. Translational psychiatry. vol 5. 2016-01-20. PMID:25826115. |
defined by features such as delusions and hallucinations, they involve cognitive dysfunction and neurotransmitter dysregulations that appear mostly to involve the dopaminergic and glutamatergic systems. |
2016-01-20 |
2023-08-13 |
Not clear |
| Jia Qi, Shiliang Zhang, Hui-Ling Wang, Huikun Wang, Jose de Jesus Aceves Buendia, Alexander F Hoffman, Carl R Lupica, Rebecca P Seal, Marisela Morale. A glutamatergic reward input from the dorsal raphe to ventral tegmental area dopamine neurons. Nature communications. vol 5. 2015-12-08. PMID:25388237. |
these findings indicate that the dr-vglut3 pathway to vta utilizes glutamate as a neurotransmitter and is a substrate linking the dr-one of the most sensitive reward sites in the brain--to vta dopaminergic neurons. |
2015-12-08 |
2023-08-13 |
Not clear |
| Evgeniy A Gorbunov, Irina A Ertuzun, Evgeniya V Kachaeva, Sergey A Tarasov, Oleg I Epstei. In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form. Neuropsychiatric disease and treatment. vol 11. 2015-11-25. PMID:26604768. |
the purpose of this study was to determine the influence of raf of abs to s100 on major neurotransmitter systems (serotoninergic, gabaergic, dopaminergic, and on sigma receptors as well) which are possibly involved in its mechanism of pharmacological activity. |
2015-11-25 |
2023-08-13 |
human |
| Isela Hernández-Plata, Magda Giordano, Mauricio Díaz-Muñoz, Verónica M Rodrígue. The herbicide glyphosate causes behavioral changes and alterations in dopaminergic markers in male Sprague-Dawley rat. Neurotoxicology. vol 46. 2015-11-12. PMID:25522657. |
additional experiments are necessary in order to unveil the specific targets of glyph on dopaminergic system, and whether glyph could be affecting other neurotransmitter systems involved in motor control. |
2015-11-12 |
2023-08-13 |
rat |
| Jacopo Vittoriano Bizzarri, Giancarlo Giupponi, Ignazio Maniscalco, Patrizia Schroffenegger, Andreas Conca, Hans Peter Kapfhamme. [Parkinson's disease and psychoses]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. vol 29. issue 1. 2015-10-27. PMID:25586068. |
different factors have been implicated, including levo-dopa and dopaminergic medications, neurotransmitter imbalances, neuroanatomic alterations, abnormal visuospatial processes, and genetic predisposition. |
2015-10-27 |
2023-08-13 |
Not clear |